GGrantIndex
← Leaderboards

David J McConkey

University Of Texas Md Anderson Can Ctr

Google Scholar ↗PubMed ↗ORCID ↗
$4,498,182
Attributed
$6,775,458
Total exposure
14
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.7M · FY2008–25
$5M$3.8M$2.5M$1.3M$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$13,887,281 · 16

By mechanism

P50$9,511,961 · 11
P01$2,108,734 · 1
R01$1,240,315 · 1
U54$593,504 · 1
R29$219,014 · 1
T32$213,753 · 1

Top collaborators

Most similar at University Of Texas Md Anderson Can Ctr

Same institution · by research overlap

Others in their field

Top investigators on “Malignant Neoplasm Of Urinary Bladder”

Research focus

Malignant Neoplasm Of Urinary BladderBaseUrogenital CancerMalignant NeoplasmsFundingProgramsApoptosisResearch PersonnelTranslational ResearchCareer DevelopmentCancer TherapyCell LineTumorLaboratoriesCostClinical TrialsCellsPlayInterestCommunicationResponseScientistUniversity Of Texas M D Anderson Cancer CenterCancer Cell

Grant awards (40)

Mechanisms of Bladder Cancer Development and Its Therapeutic Vulnerabilities to Preventive and Interventive Therapy.$2,108,734
P01 · FY2025 · CA
SPORE in Genitourinary Cancer$1,162,609
P50 · FY2018 · CA
SPORE in Genitourinary Cancer$1,910,080
P50 · FY2016 · CA
Administrative Core$218,137
P50 · FY2016 · CA
Targeting FGFR and EGFR in Bladder Cancer$215,813
P50 · FY2016 · CA · contact PI
Developmental Research Program$161,370
P50 · FY2016 · CA · contact PI
Career Development Program$160,861
P50 · FY2016 · CA
SPORE in Genitourinary Cancer$1,930,400
P50 · FY2015 · CA
Administrative Core$219,381
P50 · FY2015 · CA
Targeting FGFR and EGFR in Bladder Cancer$217,028
P50 · FY2015 · CA · contact PI
Developmental Research Program$162,009
P50 · FY2015 · CA · contact PI
Career Development Program$161,496
P50 · FY2015 · CA
Administrative Core$216,885
P50 · FY2014 · CA
Targeting FGFR and EGFR in Bladder Cancer$214,680
P50 · FY2014 · CA · contact PI
Developmental Research Program$163,044
P50 · FY2014 · CA · contact PI
Career Development Program$162,561
P50 · FY2014 · CA
Proteasome Inhibition and ER Stress$233,093
R01 · FY2013 · CA · contact PI
Administrative Core$215,641
P50 · FY2013 · CA
Targeting FGFR and EGFR in Bladder Cancer$213,501
P50 · FY2013 · CA · contact PI
Developmental Research Program$163,429
P50 · FY2013 · CA · contact PI
Career Development Program$163,429
P50 · FY2013 · CA
Proteasome Inhibition and ER Stress$247,971
R01 · FY2012 · CA · contact PI
Targeting FGFR and EGFR in Bladder Cancer$203,201
P50 · FY2012 · CA · contact PI
Administrative Core$203,200
P50 · FY2012 · CA
Developmental Research Program$203,199
P50 · FY2012 · CA · contact PI
Career Development Program$203,199
P50 · FY2012 · CA
Proteasome Inhibition and ER Stress$247,971
R01 · FY2011 · CA · contact PI
Proteasome Inhibition and ER Stress$255,640
R01 · FY2010 · CA · contact PI
Death Receptors in Bladder Cancer Therapy$239,184
P50 · FY2010 · CA · contact PI
Proteasome Inhibition and ER Stress$255,640
R01 · FY2009 · CA · contact PI
Death Receptors in Bladder Cancer Therapy$241,581
P50 · FY2009 · CA · contact PI
Death Receptors in Bladder Cancer Therapy$186,043
P50 · FY2008 · CA · contact PI
In situ detection of apoptosis in tumor endothelial cells$296,752
U54 · FY2002 · CA
DEATH RECEPTOR IN BLADDER CANCER PROGRESSION AND THERAPY$0
P50 · FY2002 · CA
In situ detection of apoptosis in tumor endothelial cells$296,752
U54 · FY2001 · CA
CALCIUM DEPENDENT MECHANISMS IN APOPTOSIS$111,177
R29 · FY2001 · CA
In situ detection of apoptosis in tumor endothelial cells$0
U54 · FY2001 · CA
DEATH RECEPTOR IN BLADDER CANCER PROGRESSION AND THERAPY$0
P50 · FY2001 · CA
JOINT TSU/UT TRAINING PROGRAM TO STUDY TOXIC MECHANISMS$213,753
T32 · FY2000 · ES
CALCIUM DEPENDENT MECHANISMS IN APOPTOSIS$107,837
R29 · FY2000 · CA